Skip to main content

Table 2 Clinical and demographic characteristics of non-diabetic patients with myocardial infarction according to blood glucose levels

From: Glucose levels as a prognostic marker in patients with ST-segment elevation myocardial infarction: a case–control study

Variable

All non-diabetic patients

Non-diabetic patients

 

Euglycemia

Moderate hyperglycemia

Severe hyperglycemia

p

Number of patients, n (%)

421

183 (43.46)

141 (33.49)

97 (23.0)

 

Age, years

61.0 (53.0-72.0)

58.0(51.0-69.0)

61.0 (55.0-73.0)

69.0(61.0-76.0)

P1–2 < 0.0001*

P1–3 < 0.0001*

Males, n (%)

300 (71.25)

143 (78.14)

98 (69.50)

59 (60.82)

P1–2 = 0.05**

P1–3 = 0.001**

AH, n (%)

367 (87.17)

165 (90.16)

116 (82.26)

86 (88.65)

P1–2 = 0.02**

Killip II – IV, n (%)

94(22.32)

22 (12.02)

28 (19.85)

44 (45.36)

P1–2 = 0.03**

P1–3 < 0.0001**

P2–3 < 0.0001**

Time before admission, hour

3.1 (1.9; 6.6)

3.0 (1.8; 8.0)

3.1 (2.0; 6.2)

3.4 (2.0; 5.5)

>0.05

Reperfusion, n (%)

250 (59.38)

102 (55.73)

88 (62.41)

60 (61.85)

>0.05

Thrombolysis, n (%)

72 (17.10)

18 (9.83)

34 (24.11)

20 (20.61)

P1–2 = 0.0005**

P1–3 = 0.01**

PCI, n (%)

213 (50.59)

93 (50.81)

69 (48.93)

51 (52.57)

>0.05

Admission blood glucose, mol/L

7.20 (6.04-8.72)

5.90 (5.21-6.4)

7.80 (7.37-8.22)

10.60 (6.33-12.70)

P1–3 = 0.003**

P2–3 = 0.001*

  1. *Mann–Whitney test; **Fisher’s test